Viveve Announces Closing of Public Offering of Shares of Common Stock
ENGLEWOOD, Colo., Dec. 11, 2018 (GLOBE NEWSWIRE) — Viveve Medical, Inc. (“Viveve”) (NASDAQ: VIVE), a medical technology company focused on […]
Aeglea BioTherapeutics Announces Design of Pivotal Phase 3 PEACE Trial Evaluating Pegzilarginase in Arginase 1 Deficiency
Single, Global Pivotal Trial to Support Registration; Primary Endpoint of Arginine Reduction Expected to Initiate in Q2 2019; Topline Data […]
First Solar Announces Full-Year 2019 Financial Guidance
Net sales of $3.25 to $3.45 billion EPS of $2.25 to $2.75, inclusive of plant-start up and ramp costs of […]
Momenta Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriter’s Option to Purchase Additional Shares
CAMBRIDGE, Mass., Dec. 11, 2018 (GLOBE NEWSWIRE) — Momenta Pharmaceuticals, Inc. (Nasdaq: MNTA), a biotechnology company with a validated scientific […]
TSX News -
Almaden Reports 42% After-Tax IRR With 203,000 ozs Gold Equivalent Production per Year Over First 6 Years From Feasibility Study for the Ixtaca Precious Metals Project, Mexico
VANCOUVER, British Columbia, Dec. 11, 2018 (GLOBE NEWSWIRE) — Almaden Minerals Ltd. (“Almaden” or “the Company”; TSX: AMM; NYSE American: […]
Fluidigm Announces Commencement of Public Offering of Common Stock
SOUTH SAN FRANCISCO, Calif., Dec. 11, 2018 (GLOBE NEWSWIRE) — Fluidigm Corporation (NASDAQ: FLDM), a leader in mass cytometry and […]
GOGL – Capital adjustment
The Board of Golden Ocean Group Limited (NASDAQ and OSE: GOGL) (“Golden Ocean” or the “Company“) announces that one holder […]
Amicus Therapeutics Awarded United Kingdom Prix Galien Medal for Galafold® (Migalastat)
First Orphan Drug to Win Prestigious “Innovative Product” Award CRANBURY, N.J. and LONDON, Dec. 11, 2018 (GLOBE NEWSWIRE) — Amicus […]
Gladstone Land Corporation Announces Common Stock Offering
MCLEAN, Va., Dec. 11, 2018 (GLOBE NEWSWIRE) — Gladstone Land Corporation (NASDAQ: LAND) (the “Company”) today announced that it plans […]
OrthoPediatrics Corp. Announces Closing of Common Stock Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
WARSAW, Ind., Dec. 11, 2018 (GLOBE NEWSWIRE) — OrthoPediatrics Corp. (“OrthoPediatrics”) (Nasdaq: KIDS), a company exclusively focused on advancing the […]
